These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7405968)

  • 21. Management of missed abortion and fetal death in utero.
    el-Damarawy H; el-Sahwi S; Toppozada M
    Prostaglandins; 1977 Sep; 14(3):583-90. PubMed ID: 905580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simpler approach to labor induction using lipid-based prostaglandin E2 vaginal suppository.
    MacKenzie IZ; Bradley S; Embrey MP
    Am J Obstet Gynecol; 1981 Sep; 141(2):158-62. PubMed ID: 6945046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of labor with prostaglandin E2 vaginal suppositories.
    Macer J; Buchanan D; Yonekura ML
    Obstet Gynecol; 1984 May; 63(5):664-8. PubMed ID: 6585734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
    Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
    Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)].
    Heinzl S
    Geburtshilfe Frauenheilkd; 1978 Mar; 38(3):220-6. PubMed ID: 640366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled trial of induction of labor by vaginal suppositories containing prostaglandin E2.
    Liggins GC
    Prostaglandins; 1979 Jul; 18(1):167-72. PubMed ID: 392623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical priming and labor induction with vaginal application of 3 mg PGE2 in suppositories in term pregnant women with premature rupture of amniotic membranes and unfavorable cervix.
    Granström L; Ekman G; Ulmsten U
    Acta Obstet Gynecol Scand; 1987; 66(5):429-31. PubMed ID: 3480677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current status of prostaglandins as abortifacients.
    Brenner WE
    Am J Obstet Gynecol; 1975 Oct; 123(3):306-28. PubMed ID: 810025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
    Bailey CD; Newman C; Ellinas SP; Anderson GG
    Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 32. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
    Schmidt W; Widmaier G; Ditz S; Kubli F
    Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandins: overview in obstetrics and gynecology.
    Singh EJ; Zuspan FP
    J Reprod Med; 1974 May; 12(5):211-4. PubMed ID: 4599109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
    Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
    Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experiences with prostaglandin E 2 and F 2 alpha in the termination of pregnancy and labor induction in intrauterine fetal death].
    Kunz J; Schreiner WE
    Schweiz Med Wochenschr; 1977 Jun; 107(22):757-63. PubMed ID: 877524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous prostaglandin E2 and 16-phenoxy prostaglandin E2 methyl sulfonylamide for induction of fetal death in utero.
    Gruber WS; Baumgarten K
    Am J Obstet Gynecol; 1980 May; 137(1):8-14. PubMed ID: 7369292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dramatic pyrexic and cardiovascular response to intravaginal prostaglandin E2.
    Phelan JP; Meguiar RV; Matey D; Newman C
    Am J Obstet Gynecol; 1978 Sep; 132(1):28-32. PubMed ID: 696780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J; Hauth JC
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.